Search - tctmd.com

Displaying 461 - 480 of 1502

Sort: Relevancy | Date

Presentation

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Presenter: Sebastian Kufner

June 02, 2015

Presentation

Impact of Strut Width in Periprocedural MI

Presenter: H. Kawamoto

June 01, 2015

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

Presentation Fellows 2015

Drug-Eluting Stents: Past, Present, and Future

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation ARCH 2015

Below the Knee Stenting

Presenter: George S. Chrysant

April 10, 2015

Presentation ARCH 2015

How to Approach In-Stent Restenosis

Presenter: Craig M. Walker

April 10, 2015

Presentation ARCH 2015

DEB - BVS

Presenter: George S. Chrysant

April 10, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Presentation

Short- vs Long-term Dual Antiplatelet Therapy After DES Implantation

Presenter: T. Palmerini

March 18, 2015

Presentation

One-Year Clinical Outcomes of the STENTYS Self-Apposing Coronary Stent in Patients With STEMI

Presenter: Karel T. Koch

March 12, 2015

Presentation

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

Presenter: S Habara

March 01, 2015

Presentation

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Presenter: A.Puricel

February 26, 2015

Presentation

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Presenter: Marco Valgimigli

February 23, 2015

Presentation CADECI 2015

Carotid Artery Stenting: Risk Stratification and Patient Selection

Presenter: Hugo Londero

February 20, 2015

Presentation CADECI 2015

Subclinical CV Disease Heart – Brain Integration

Presenter: CADECI 2015

February 19, 2015

Presentation CADECI 2015

Sistema de protección proximal en angioplastía carotídea_

Presenter: Juan Carlos Parodi

February 19, 2015

Presentation CADECI 2015

The future of Drug-Eluting Stent

Presenter: Renu Virmani

February 18, 2015

Presentation CADECI 2015

The evolution of catheter cryoablationfrom focal to cryoballoon technology

Presenter: Marc Dubuc

February 18, 2015

Presentation

RCT of a Dedicated Bifurcation Stent vs Provisional Stenting for Coronary Bifurcation Lesions

Presenter: P. G?n?reux

February 11, 2015

Advertisement

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Impact of Strut Width in Periprocedural MI

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Drug-Eluting Stents: Past, Present, and Future

Below the Knee Stenting

How to Approach In-Stent Restenosis

DEB - BVS

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Short- vs Long-term Dual Antiplatelet Therapy After DES Implantation

One-Year Clinical Outcomes of the STENTYS Self-Apposing Coronary Stent in Patients With STEMI

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Carotid Artery Stenting: Risk Stratification and Patient Selection

Subclinical CV Disease Heart – Brain Integration

Sistema de protección proximal en angioplastía carotídea_

The future of Drug-Eluting Stent

The evolution of catheter cryoablationfrom focal to cryoballoon technology

RCT of a Dedicated Bifurcation Stent vs Provisional Stenting for Coronary Bifurcation Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content